Thirumazhisai Gunasekaran

Summary

Affiliation: Advocate Christ Medical Center
Country: USA

Publications

  1. doi request reprint Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population
    T S Gunasekaran
    Division of Pediatric Gastroenterology and Nutrition, Advocate Lutheran General Children s Hospital, 1775 Dempster Street, Park Ridge, IL 60068, USA
    Dig Dis Sci 53:2373-9. 2008
  2. pmc Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
    Thirumazhisai Gunasekaran
    Lutheran General Children s Hospital, Park Ridge, IL 60068, USA
    BMC Gastroenterol 9:84. 2009
  3. doi request reprint Prevalence of gastroesophageal reflux symptoms in adolescents: is there a difference in different racial and ethnic groups?
    T S Gunasekaran
    Esophageal Center and Division of Pediatric Gastroenterology and Nutrition, Advocate Lutheran General Children s Hospital, Park Ridge, Illinois, USA
    Dis Esophagus 24:18-24. 2011
  4. ncbi request reprint Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease
    Benjamin D Gold
    Division of Pediatric Gastroenterology and Nutrition, Emory University School of Medicine, 2015 Uppergate Dr, Atlanta, GA 30322, USA
    J Pediatr Gastroenterol Nutr 45:520-9. 2007
  5. ncbi request reprint Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability
    Thirumazhisai Gunasekaran
    Center for Children s Digestive Health, Lutheran General Children s Hospital, Park Ridge, Illinois 60068, USA
    J Pediatr Gastroenterol Nutr 35:S327-35. 2002

Detail Information

Publications5

  1. doi request reprint Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population
    T S Gunasekaran
    Division of Pediatric Gastroenterology and Nutrition, Advocate Lutheran General Children s Hospital, 1775 Dempster Street, Park Ridge, IL 60068, USA
    Dig Dis Sci 53:2373-9. 2008
    ..To determine the prevalence of esophageal symptoms and associated symptoms of gastroesophageal reflux symptoms in 14-18 year-old high school students and the percentage of symptomatic adolescents who saw a physician or received medications...
  2. pmc Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
    Thirumazhisai Gunasekaran
    Lutheran General Children s Hospital, Park Ridge, IL 60068, USA
    BMC Gastroenterol 9:84. 2009
    ..Therefore, the objective of the study was to examine the effect of GERD on HRQOL in adolescents...
  3. doi request reprint Prevalence of gastroesophageal reflux symptoms in adolescents: is there a difference in different racial and ethnic groups?
    T S Gunasekaran
    Esophageal Center and Division of Pediatric Gastroenterology and Nutrition, Advocate Lutheran General Children s Hospital, Park Ridge, Illinois, USA
    Dis Esophagus 24:18-24. 2011
    ..Future research should focus on whether the differences found continue and reasons for them...
  4. ncbi request reprint Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease
    Benjamin D Gold
    Division of Pediatric Gastroenterology and Nutrition, Emory University School of Medicine, 2015 Uppergate Dr, Atlanta, GA 30322, USA
    J Pediatr Gastroenterol Nutr 45:520-9. 2007
    ..A secondary aim was to assess changes in GERD symptoms after esomeprazole therapy...
  5. ncbi request reprint Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability
    Thirumazhisai Gunasekaran
    Center for Children s Digestive Health, Lutheran General Children s Hospital, Park Ridge, Illinois 60068, USA
    J Pediatr Gastroenterol Nutr 35:S327-35. 2002
    ..To evaluate the pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability of lansoprazole in adolescents between 12 and 17 years of age with gastroesophageal reflux disease (GERD)...